Exact Sciences (EXAS) stock has shown strong gains recently, and Wall Street analysts are predicting even more upside potential. While the average price target indicates a significant gain, it’s important to understand the nuances of analyst predictions. This article explores the factors driving analysts’ optimism and why earnings estimate revisions might be a more reliable indicator of near-term stock performance.